Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Muhammed Enes Tasci has a total of 20 co-authors. Here are the top co-authors by number of shared publications:

  • Anton Ficai

    National Research Center for Micro and Nanomaterials, Faculty of Chemical Engineering and Biotechnologies, National University of Science and Technology POLITEHNICA Bucharest, Splaiul Independentei 313, 060042 Bucharest, Romania

    1 shared publication
  • Aybuke Gur

    Center for Nanotechnology & Biomaterials Application and Research (NBUAM), Marmara University, İstanbul 34000, Turkey

    1 shared publication
  • Berna Dede

    Center for Nanotechnology & Biomaterials Application and Research (NBUAM), Marmara University, İstanbul 34000, Turkey

    1 shared publication
  • Betul Buse Karabıyık

    Department of Pulmonary Diseases, Istanbul University, Istanbul Medical Faculty, Istanbul, Turkey, Turkey (Türkiye)

    1 shared publication
  • Chi-Chang Lin

    Department of Chemical and Materials Engineering, Tunghai University, Taiwan

    1 shared publication
  • Denisa Ficai

    National Research Center for Micro and Nanomaterials, Faculty of Chemical Engineering and Biotechnologies, National University of Science and Technology POLITEHNICA Bucharest, Splaiul Independentei 313, 060042 Bucharest, Romania

    1 shared publication

Latest Publications

  • Open Access

    Semi-Automated Quantitative CT at Diagnosis and One Year in Idiopathic Pulmonary Fibrosis: Associations with Functional and Prognostic Indices

    by Emine Bensu Erdemir, Gorkem Durak, Betul Buse Karabıyık, Muhammed Enes Tasci, Sukru Mehmet Erturk, Ulas Bagci, Nigar Gulfer Okumus, Zuleyha Bingol

    Background: Idiopathic pulmonary fibrosis (IPF) is a devastating chronic lung disease with an incompletely understood course. Limited quantitative tools complicate consistent patient assessment, and visual evaluation of radiological progression varies between observers. This study aimed to assess baseline and one-year CT scans using artificial intelligence (AI)–assisted 3D quantitative Computed Tomography (QCT), integrating radiological changes with clinical findings to objectively characterize disease progression and examine its association with prognosis. Methods: In this retrospective cohort of 83 patients with IPF, we evaluated patients using an AI-assisted quantitative CT framework for prognostic assessment. Whole-lung segmentation was performed using a pretrained deep learning model (LungMask), followed by semi-automated segmentation of fibrotic abnormalities with radiologist-guided refinement. Quantitative imaging biomarkers, including honeycombing volume, non-honeycomb fibrotic lung volume, preserved lung volume, and the pathological lung volume-to-total lung volume ratio, were derived from 3D QCT analysis. Baseline and one-year measurements and their changes were evaluated in relation to mortality, pulmonary function test, gender, age, physiology score (GAP) index, and composite physiologic index (CPI). Between-group comparisons were performed using the Mann–Whitney U test, paired comparisons using the Wilcoxon signed-rank test, and correlations using Spearman’s rank correlation analysis. Statistical analyses were conducted using SPSS version 27.0. Results: A total of 83 patients with IPF were included in the study (mean age: 64.1 ± 8.5 years; 69.9% male). First-year mortality was 14.5% (n = 12), and overall mortality was 37.3% (n = 31) over a median follow-up of 48 months. Compared with the survival group, the mortality group had greater baseline non-honeycomb fibrotic lung volume (1002.2 ml ± 532.3 vs. 628.4 ± 460.2), a higher pathological-to-total lung volume ratio, comprising honeycomb and non-honeycomb fibrosis (0.34 ± 0.16 vs. 0.18 ± 0.15), and lower preserved lung volume (2317.9 ± 961.4 vs. 3531.6 ± 1579.2; all p < 0.001). Over one year, honeycomb and non-honeycomb fibrotic lung volume ratios increased, while the preserved lung volume ratio decreased in both groups (all p < 0.05). Patients with a 10% forced vital capacity (FVC) decline had a greater increase in the non-honeycomb fibrotic-to-total lung volume ratio (0.08 ± 0.10 vs. 0.02 ± 0.20; p = 0.044). The baseline pathological-to-total lung volume ratio correlated with baseline GAP (r = 0.343, p = 0.002), baseline CPI (r = 0.431, p < 0.001), and one-year CPI (r = 0.560, p < 0.001). One-year QCT changes did not differ significantly between the mortality and survival groups. Conclusion: 3D semi-automated, AI-assisted QCT provided an objective assessment of radiological progression in IPF. Greater baseline fibrotic involvement and lower preserved lung volume were associated with mortality, and quantitative imaging measures correlated with GAP and CPI. Although one-year QCT changes did not differ by mortality status, increased non-honeycomb fibrotic involvement was associated with FVC decline. These findings support QCT as a complementary tool for assessing disease extent and progression alongside functional and prognostic indices.

  • External traction technique during endoscopic submucosal dissection – a video vignette

    by Kamil Erozkan, Muhammed Enes Tasci, Emre Gorgun

  • Open Access

    Production, Optimization and Characterization of Polylactic Acid Microparticles Using Electrospray with Porous Structure

    by Muhammed Enes Tasci, Berna Dede, Eray Tabak, Aybuke Gur, Rabia Betul Sulutas, Sumeyye Cesur, Elif Ilhan, Chi-Chang Lin, Pradip Paik, Denisa Ficai, et al.

    Polymeric microparticles with controlled morphologies and sizes are being studied by researchers in many applications, such as for drug release, healthcare and cosmetics. Herein, spherical and porous polymeric microparticles of different sizes and morphologies by electrospray technique have been developed as a viable alternative. In this work, polylactic acid (PLA) microparticles with a spherical shape and porous morphology were successfully produced via an electrospray technique in a single step. Molecular interactions between the components and the effect of parameters, such as varying solvent compositions, flow rates and voltage on microparticle morphology, were investigated over the particle formation. It was observed that the type of solvents used is the most effective parameter in terms of particle morphology, size and distribution. When the optical microscopy and SEM images of the microparticles were examined, 3 wt.% PLA in dichloromethane (DCM) solution concentration with an applied voltage of 18 kV and a flow rate of 20 µL/min was found to be the optimum parameter combination to achieve the desired spherical and porous micron-size particles. The average diameter of the particles achieved was 3.01 ± 0.58 µm. DCM was found to be a more suitable solvent for obtaining microparticles compared to the other solvents used. Finally, particles that are obtained by electrospraying of PLA–DCM solution are porous and monodisperse. They might have excellent potential as a carrier of drugs to the targeted sides and can be used in different biomedical applications.